NRx Pharmaceuticals, Inc.
NRXP
$2.27
-$0.02-0.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.33% | -13.28% | 43.90% | -71.29% | -48.38% |
| Total Receivables | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 80.20% | -25.16% | 100.37% | -24.15% | -35.29% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -2.83% | 2.17% | -12.72% | 9.18% | -56.43% |
| Total Current Assets | -19.58% | -15.86% | 45.80% | -51.38% | -47.41% |
|
|
|||||
| Total Current Assets | -19.58% | -15.86% | 45.80% | -51.38% | -47.41% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.97% | -7.29% | -12.93% | 2.32% | 1,952.38% |
| Total Assets | -18.18% | -15.24% | 38.97% | -48.22% | -44.20% |
|
|
|||||
| Total Accounts Payable | -15.13% | -2.97% | -19.95% | 35.25% | 27.57% |
| Total Accrued Expenses | 194.50% | -19.41% | 23.64% | 10.48% | -1.23% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -59.15% | -60.14% | 12.86% | -26.00% | -9.02% |
| Total Finance Division Other Current Liabilities | 141.70% | 72.59% | 14,646.15% | 52.94% | -94.75% |
| Total Other Current Liabilities | 141.70% | 72.59% | 14,646.15% | 52.94% | -94.75% |
| Total Current Liabilities | 7.70% | -14.19% | 25.44% | -1.00% | -1.44% |
|
|
|||||
| Total Current Liabilities | 7.70% | -14.19% | 25.44% | -1.00% | -1.44% |
| Long-Term Debt | 67.87% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.42% | -1.57% | 25.44% | -1.00% | -1.44% |
|
|
|||||
| Common Stock & APIC | 1.87% | 0.48% | 1.87% | 1.32% | -0.50% |
| Retained Earnings | -3.37% | -0.61% | -3.04% | -2.58% | -1.74% |
| Treasury Stock & Other | -- | -- | 0.00% | 0.00% | 86.36% |
| Total Common Equity | -23.38% | -2.34% | -22.05% | -28.40% | -88.68% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
|
|
|||||
| Total Common Equity | -23.38% | -2.34% | -22.05% | -28.40% | -88.68% |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -23.38% | -2.34% | -22.05% | -28.43% | -88.72% |
|
|
|||||